A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

NCT06860282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Coronavirus Pneumonia

Interventions

DRUG: Remdesivir
DRUG: CX2101A
DRUG: Placebo

Sponsor

Heronova Pharmaceuticals